Crosseal Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

This Crosseal market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The growth during the historic period can be attributed to the rising demand for minimally invasive surgeries, increased awareness of the benefits of biological adhesives for wound healing, and a growing geriatric population.

The growth projected for the forecast period is driven by the expansion of healthcare infrastructure in emerging markets, ongoing innovations in regenerative medicine, the rising prevalence of chronic diseases, a growing emphasis on faster recovery, and increased demand for biocompatible adhesives. Key trends during this period include the integration of smart sealing technologies, the use of bio-based and sustainable materials, a shift toward high-performance seals for extreme conditions, advancements in multi-functional sealing solutions, the adoption of 3D printing technologies for sealing solutions, and a growing demand for customized sealing products.

The growing number of injuries is anticipated to drive the expansion of the crosseal market in the coming years. Injuries, defined as physical harm or damage to the body caused by external forces, trauma, or adverse conditions such as accidents, falls, or violence, are on the rise due to factors such as urbanization, increased road traffic, unsafe work environments, lifestyle changes, and the growing prevalence of violence and natural disasters. Crosseal addresses the needs of injured patients by offering advanced tissue-sealing solutions that promote rapid hemostasis, reduce surgical complications, and support faster recovery, leading to improved treatment outcomes. For instance, the World Health Organization (WHO) reported in June 2024 that injuries and violence account for 4.4 million deaths annually, representing nearly 8% of global fatalities. This rise in injuries is fueling the growth of the crosseal market.

The increasing prevalence of minimally invasive surgeries is expected to further bolster the growth of the crosseal market. Minimally invasive surgeries (MIS), which involve procedures performed through small incisions or natural body openings using specialized instruments and techniques, are becoming more common due to advancements in medical technology and patient preference for methods offering shorter recovery times and reduced post-operative pain. Crosseal contributes to these procedures by ensuring effective hemostasis, minimizing bleeding risks, and promoting quicker healing, thereby enhancing patient outcomes and optimizing surgical processes. For example, the American Academy of Facial Plastic and Reconstructive Surgery reported in February 2024 that 83% of all medical procedures conducted in 2023 were minimally invasive, with only 17% being traditional surgical methods. Additionally, the American Society of Plastic Surgeons noted that the total number of cosmetic minimally invasive procedures grew from 23.7 million in 2022 to 25.4 million in 2023. The rise in minimally invasive surgeries is thus driving demand for crosseal.

The growth in healthcare spending is also expected to accelerate the expansion of the crosseal market. Healthcare spending, which includes expenditures on medical care, hospital services, preventive care, medications, research, infrastructure, and administrative costs, is increasing due to an aging population, advancements in medical technology, the rising prevalence of chronic diseases, and growing demand for healthcare services. This rising expenditure supports crosseal by highlighting the importance of effective hemostatic agents to improve patient outcomes and enhance healthcare efficiency. For instance, the Office for National Statistics reported in May 2024 that healthcare spending in the UK grew by 5.6% between 2022 and 2023, compared to a 0.9% increase in 2022. Total healthcare expenditure in the UK reached approximately $317.63 billion (£292 billion) in 2023. This increase in healthcare spending is a key factor driving the growth of the crosseal market.

The key company operating in the crosseal market is Omrix Biopharmaceuticals Inc.

North America was the largest region in the crosseal market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in crosseal report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the crosseal market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Crosseal is the brand name for a fibrin sealant, a type of biological adhesive used in surgical procedures to achieve hemostasis and promote tissue healing. Composed of fibrinogen and thrombin, these sealants replicate the final stages of the natural blood clotting process, forming clots that seal tissue and control bleeding.

Crosseal includes fibrin sealants, synthetic sealants, and hemostatic agents. Fibrin sealants, specifically, are biological adhesives derived from fibrinogen and thrombin, key blood components that facilitate clotting. The product is utilized across various surgical applications, including orthopedic, cardiac, general, liver, and gynecological surgeries. Distribution channels include hospital pharmacies, surgical supply distributors, and outpatient surgery centers.

The crosseal market research report is one of a series of new reports that provides crosseal market statistics, including crosseal industry global market size, regional shares, competitors with a crosseal market share, detailed Crossealmarket segments, market trends, and opportunities, and any further data you may need to thrive in the crosseal industry. This crosseal market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The crosseal market consists of sales of tissue sealants and biological glues. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.